Alterations in regulators of the alternative pathway in human NASH.

Filip M. Segers(Maastricht University Medical Centre), Sander S. Rensen(Maastricht University Medical Centre), Charlotte de Jonge(Maastricht University Medical Centre), Nicole D. Bouvy(Maastricht University), Ann Driessen(University of Antwerp), Bas Boonen(Maastricht University Medical Centre), Wim A. Buurman(Unknown), Jan Greve(Maastricht University), Ronit Shiri‐Sverdlov(Maastricht University), Froukje J. Verdam(Maastricht University Medical Centre)
Figshare
December 2, 2015
10.1371/journal.pone.0110053.g003
Cited by 0

Related Papers

The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
|Thorax|1996|524
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
|Hepatology|2008|467
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
|Nature Communications|2013|298
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
|Journal of Hepatology|2005|241